Change - Announcement of Cessation::Cessation of Executive Director and Director of Strategy & Capital Markets

Issuer & Securities

Issuer/ Manager
QT VASCULAR LTD.
Securities
QT VASCULAR LTD. - SG2G82000008 - 5I0
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
24-May-2019 20:00:44
Status
New
Announcement Sub Title
Cessation of Executive Director and Director of Strategy & Capital Markets
Announcement Reference
SG190524OTHRS2L2
Submitted By (Co./ Ind. Name)
Eitan Konstantino
Designation
Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Announcement on the cessation of Gary Ng Sin Tong as Executive Director and Director of Strategy & Capital Markets of the Company.

This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor") in accordance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms. Gillian Goh, Director, Head of Continuing Sponsorship (Mailing Address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and Email: sponsorship@ppcf.com.sg).

Additional Details

Name Of Person
Gary Ng Sin Tong
Age
45
Is effective date of cessation known?
Yes
If yes, please provide the date
24/05/2019
Detailed Reason (s) for cessation
To pursue other career opportunities.

Following the cessation of Mr. Gary Ng as a Director of the Company, Mr. Gary Ng will continue to be available to assist Dr. Eitan Konstantino, the Company's Chief Executive Officer, on an as needed basis under a mutually agreed transition plan. Dr. Konstantino will be directly responsible for managing stakeholder engagements and any fundraising activities. He will also be supported by Mr. Kelvin Tong, the Group's Financial Controller, in this aspect.

Based on its enquiries, the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. is satisfied that, other than as disclosed in this announcement, there are no other material reasons for the cessation of Gary Ng Sin Tong as Executive Director and Director of Strategy & Capital Markets of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
06/08/2015
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
1
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
0
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and Director of Strategy & Capital Markets
Role and responsibilities
Responsible for engaging with stakeholders and raising funds from the Singapore capital market.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
None
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
5,442,243 ordinary shares in the Company

1,215,000 options exercisable into 1,215,000 ordinary shares in the Company
Past (for the last 5 years)
Nil
Present
Nil